The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business planning, and satisfy requirements of purchasers of technology. Participants…
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Christopher McCabe, Executive Director and CEO of the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dan Palfrey, Director, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Andrew Sutton, Senior Health Economist, Health Technology Innovation Platform at the Institute of Health Economics.
HTIP Health Economics Educational Workshop
PDF of a PowerPoint presentation by Dr. Kelvin Chan MD FRCPC MSc (Clin Epi) MSc (Biostats) PhD, Sunnybrook Odette Cancer Centre.
IHE/CAPT Real World Evidence Workshop
PDF of a PowerPoint presentation by Dr. Tammy Clifford, Chief Scientist and Vice-President, Evidence Standards, and Dr. Trevor Richter, Director, Common Drug Review and Optimal Use at CADTH.
IHE/CAPT Real World Evidence Workshop
On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the 2018 CAPT conference in Toronto,…
In the development of early stage life sciences technology, it's imperative to understand whether healthcare organizations are likely to purchase your innovation, and consequently provide a return on investment. Healthcare organizations make purchase decisions based upon clinical AND economic (value for money) considerations. Our early stage technology assessment service can help…
Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
The Institute of Health Economics (IHE) is a unique collaborative arrangement among government, academia, and industry. Established in 1995, the IHE is committed to gathering and disseminating evidence-based findings from health economics, health policy, health technology assessment and comparative effectiveness research to support health policy and practice.
This clinical practice guideline was produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use of public funds. This project…
This background document outlines the methods used to develop the Criteria for the Clinical Use of Immune Globulin, which was produced as part of the Prairie Collaborative Immune Globulin Utilization Management Framework project. The Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project was initiated to establish criteria for IG therapy as a means…
PDF of a PowerPoint Presentation by George Habib, President and CEO, Lung Association of Ontario.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of a PowerPoint presentation by Shelley Valaire, Senior Provincial Director, Respiratory Health Strategic Clinical Network (RHSCN), Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
PDF of PowerPoint presentation by Tatiana Makhinova, Assistant Professor, Faculty of Pharmacy and Pharmaceutical Services, University of Alberta.
Facilitating Adoption of Innovation Practices (COPD) Panel – HTAi Annual Meeting 2018
This brief outlines some perspectives from the Institute of Health Economics (IHE) based on what we have heard from government, public agencies, and industry, and seeks to summarize the key areas where further clarification and deliberation could be helpful.
PDF of a PowerPoint presentation by Dr. Brian O’Rourke, CEO, Canadian Agency for Drugs and Technology in Health.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
PDF of a PowerPoint presentation by Dr. Sean Tunis, President, Health Technology Assessment International; Founder and CEO, Centre for Medical Technology Policy.
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum
| Sue Ludwig, Patricia Leggett Tait, Christa Harstall
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #22. This review was requested to determine whether conductive education as a learning approach or therapeutic intervention is safe and efficacious for children with disabilities such as cerebral palsy that impact neuromotor functioning. The review also addresses the profile of the child who would benefit from…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #18. This report has been prepared following interest by the Alberta Cord Blood Bank in obtaining advice on the comparative effectiveness and costs of different types of stem cell transplantation. Earlier assessments by the Foundation have considered peripheral blood stem cell transplantation and cord blood transplantation.…